Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|27|3116-3132

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.27, 2009-09, pp. : 3116-3132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field

By Whatling Carl   McPheat William   Herslöf Margareta  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1879-1893

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of cyclooxygenase-2 and 5-lipoxygenase

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 9, 1997-09 ,pp. : 1041-1042

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in 5lipoxygenase inhibitors

By Julémont Fabien   Dogné Jean-Michel   Laeckmann Didier   Pirotte Bernard   Leval Xavier de  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 1-13

Informa Healthcare

Access to resources Recommend Favorite

5-Lipoxygenase inhibitors: a review of recent developments and patents

By Pergola Carlo   Werz Oliver  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 3, 2010-03 ,pp. : 355-375

Informa Healthcare

Access to resources Recommend Favorite

5-Lipoxygenase inhibitors: a patent evaluation (WO2011161615)

By Buscató Estel.la   Proschak Ewgenij  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 7, 2012-07 ,pp. : 843-846

Informa Healthcare

Access to resources Recommend Favorite